Tuesday August 4, 2020

HSE’s mounting drug budget needs a shot of strong medicine

Some new treatments cost well over €100,000 per patient, but there are effective ways to rein in expenditure

5th January, 2020

There has been much criticism of the finite drug budget we have in the health service. Last year, even though the HSE invested heavily and funded 29 new medicines, new approvals stalled.

Affordability has become a real issue, even though drug expenditure in Ireland is likely to exceed €2.5 billion in 2019. That represents approximately 17 per cent of total healthcare expenditure in 2019.

Some new drug therapies cost well over €100,000 per patient per year and are frequently...

Subscribe from just €1 for the first month!

Exclusive offers:

All Digital Access + eReader

Trial

€1

Unlimited Access for 1 Month

Then €19.99 a month after the offer period.

Get basic
*New subscribers only
You can cancel any time.

Annual

€200

€149 For the 1st Year

Unlimited Access for 1 Year

You can cancel any time.

Quarterly

€55

€42

90 Day Pass

You can cancel any time.

2 Yearly

€315

€248

Unlimited Access for 2 Years

This product does not auto-renew

Team Pass

Get a Business Account for you and your team

Related Stories

A new study has revealed this country ranks 19th out of 34 European countries, with patients waiting an average of 521 days

Daniel Murray | 2 days ago

The final phase of the country’s reopening and the approach of winter pose serious challenges to our Covid-19 test-and-trace system

Danielle Barron | 2 days ago

As Spain insists large areas of the country are safe for tourists, does stopping or restricting travel have a material impact on the spread of Covid-19?

Aaron Rogan | 2 days ago